View Clinical Trial (Medical Research Study)
A Study of Intravenous Tamiflu (Oseltamivir) in Children With Influenza - NCT01033734-11203(Clinical Trial 648345)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Brooklyn |
|
State:
|
|
NY |
| Zip Code: |
|
11203 |
| Conditions: |
|
Influenza |
| Purpose: |
|
This open-label study will assess the pharmacokinetics/pharmacodynamics and safety of
intravenous (iv) Tamiflu (oseltamivir) in 3 cohorts of children, aged 6-12, 3-5 and 1-2
years, with influenza infection. Patients will receive iv Tamiflu therapy for 5 days (10
doses). For patients whose conditions no longer merit continued iv dosing, therapy may be
switched to oral Tamiflu to complete their prescribed course of treatment. If medically
necessary, iv or oral therapy with Tamiflu may be continued for up to 5 additional days.
Anticipated time on study treatment is 5 to 10 days.
|
| Study summary: |
|
|
| Criteria: |
|
Inclusion Criteria:
- children, 1-12 years of age
- diagnosis of influenza
- duration of influenza symptoms </=96 hours prior to first dose of study drug
Exclusion Criteria:
- evidence of severe hepatic decompensation
- patients taking probenecid within 1 week prior to first dose of study drug |
|
|
|
| Study is available at: |
|
Brooklyn, NY 11203
United States
Primary Contact:
Please reference Study ID Number: NP25139
Email: genentechclinicaltrials@druginfo.com
Phone: 888-662-6728 (U.S. Only) |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 23, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|